Medicaid Managed Care - U.S. Senate Special Committee on Aging
Medicaid Managed Care - U.S. Senate Special Committee on Aging
Medicaid Managed Care - U.S. Senate Special Committee on Aging
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
order) were followed. Samplingpatients<br />
with the same diagnoses across systems<br />
of care and measuring them with the<br />
same methods allowed more valid comparis<strong>on</strong>s<br />
of outcomes across plans. To<br />
better address policy issues, the MOS<br />
oversampled the elderly and the poor.<br />
Focusing <strong>on</strong> chr<strong>on</strong>ically ill patients and<br />
oversampling of the elderly and poor<br />
increased the likelihood of detecting differences<br />
in health outcomes because<br />
these subgroups account for a disproporti<strong>on</strong>ate<br />
share of health care expenditures<br />
and are, therefore, prime targets<br />
of cost c<strong>on</strong>tainment<br />
We report here the results of comparing<br />
changes in physical and mental<br />
health states between FFS and HMO<br />
systems, measured over a 4-year period.<br />
In c<strong>on</strong>trast to previous MOS reports<br />
of outcomes for the average patient,<br />
we focus <strong>on</strong> outcomes for policyrelevant<br />
subgroups-including patients<br />
aged 65 years and older covered by<br />
Medicare and those near and below the<br />
poverty line. Further, results are reported<br />
for patients across all of the<br />
c<strong>on</strong>diti<strong>on</strong>s sampled in the MOS and not<br />
just for patients with hypertensi<strong>on</strong> and<br />
NIDDM' and mental disorders."<br />
METHODS<br />
The MOS was an observati<strong>on</strong>al study<br />
of variati<strong>on</strong>s in practice styles and of<br />
outcomes forchr<strong>on</strong>icaly ill adults treated<br />
in staff-model and independent practice<br />
HMOs vs FFS care in large multispecialty<br />
groups, small, single-specialty<br />
groups, and solo practices serving the<br />
same areas. Details of the MOS design,<br />
including site selecti<strong>on</strong>, sampling, clinician<br />
and patient recruitment, and data<br />
collecti<strong>on</strong> methods are documented<br />
elsewhere."' To briefly recap the study<br />
design, MOS sites included Bost<strong>on</strong>,<br />
Mass, Chicago, Ill, and Los Angeles,<br />
Calif, which represent 3 of the 4 US<br />
census regi<strong>on</strong>s. When sampling began<br />
in 1986 and 1987, these cities included<br />
well-developed HMO and FFS plans,<br />
including 2 of the country's largest<br />
HMOs employing salaried physicians<br />
and 2 of the largest independent practice<br />
associati<strong>on</strong> (IPA) networks. In each<br />
city, 5 or 6 practice sites were sampled<br />
from each group practice HMO. The<br />
physician sample included 206 general<br />
internists, 87 family practiti<strong>on</strong>ers, 42<br />
cardiologists, 27 endocrinologists, and<br />
65 psychiatrists. In HMOs, patients<br />
treated by 8 nurse practiti<strong>on</strong>ers were<br />
also sampled. In additi<strong>on</strong>, patients with<br />
a depressive disorder were sampled<br />
from the practices of 59 clinical psychologists<br />
and 9 social workers. Clinicians<br />
averaged 39.6 years of age; 22%<br />
were female, and 29% were internati<strong>on</strong>al<br />
medical graduates.<br />
1040 JAMA. Cc7.0be, 2. 1996--Val 276, No. 13<br />
158<br />
Patient Sampling and Characterstics<br />
Patients followed up l<strong>on</strong>gitudinally<br />
were selected from 28257 adults who<br />
visited an MOS site i 1986; 71.6% agreed<br />
to participate. In 18794 (92.9%) of the<br />
visits, a standardized screening form was<br />
completed both by the MOS clinician<br />
and the patient. Using criteria documented<br />
elsewhere,' clinicians identified<br />
patients with hypertensi<strong>on</strong>, NIDDM,<br />
myocardial infarcti<strong>on</strong> within the past 6<br />
m<strong>on</strong>ths, and c<strong>on</strong>gestive heart failure.<br />
Patients with depressive disorder were<br />
identified independently in a 2-stage<br />
screen, which included a patient-completed<br />
form and a computer-assisted diagnostic<br />
interview by teleph<strong>on</strong>e' 80%<br />
of those c<strong>on</strong>tacted completed this screening<br />
process.<br />
Patients were selected for follow-up<br />
<strong>on</strong> the basis of diagnosis and participati<strong>on</strong><br />
in baseline data collecti<strong>on</strong>, as documented<br />
in detail elsewhere.' Inclusi<strong>on</strong><br />
of patients with more than 1 of the 5<br />
c<strong>on</strong>diti<strong>on</strong>s, with or without other comorbidities,<br />
allowed for a more generalizable<br />
study. Of the 3589 eligible patients,<br />
2708 (75.5%) completed a baseline assessment.<br />
We randomly selected 2225<br />
of these for follow-up, by chr<strong>on</strong>ic c<strong>on</strong>diti<strong>on</strong><br />
and severity of their disease. A<br />
patient sample of this size was sufficient<br />
to detect clinically and socially relevant<br />
differences in health outcomes, defined<br />
as an average difference of 2 points or<br />
larger <strong>on</strong> a scale of 0 to 100,' in a comparis<strong>on</strong><br />
between HMO and FFS systems.<br />
Specifically, the statistical power<br />
was greater than 80%, with a at the .05<br />
level for a 2-tailed test.<br />
Patients ranged from 18 to 97 years of<br />
age, with a mean just under 58 years. At<br />
baseline, 36.8% were 65 years of age or<br />
older, all but 1 reported being covered<br />
by Medicare. (An additi<strong>on</strong>al 144 patients<br />
aged into thin group during the 4-year<br />
follow-up.) A slight majority (54%) were<br />
female. About 22% were at or below<br />
200% of the poverty line; 16% of those<br />
reported being covered by <str<strong>on</strong>g>Medicaid</str<strong>on</strong>g>.<br />
Three of 10 eligible for Medicare were<br />
also in the poverty group. Three of4 had<br />
completed at least a 12th grade educati<strong>on</strong>;<br />
about I is 5 was n<strong>on</strong>white.<br />
Patients sampled had the following diagnoses<br />
hypertensi<strong>on</strong> (n=13 18 ), NIDDM<br />
(n=441), c<strong>on</strong>gestive heart failure (n=215),<br />
recent acute myocardial infarcti<strong>on</strong><br />
(n=104), and depressive disorder (n=44 4 ).<br />
(These numbers add to more than 2235<br />
because some patients had more than<br />
<strong>on</strong>e c<strong>on</strong>diti<strong>on</strong>.)'' As in previous MOS<br />
analyses,' FFS patients followed up in<br />
this study were significantly older (41.9<br />
vs 32.9 years <strong>on</strong> average) than HMO patients,<br />
were more likely to be female<br />
(62.8% vs 57.8%), and were more likely<br />
to be in the poverty group (25.4% vs<br />
18.1%). The FFS patients followed were<br />
also more likely to have c<strong>on</strong>gestive heart<br />
failure (1138% vs 7.3%) and to have had<br />
a recent myocardial infarcti<strong>on</strong> (8.9% vs<br />
3.4%). As documented in detail elsewhere<br />
(MOS unpublished data; see acknowledgment<br />
footnote at the end of this<br />
article for availability of all MOS unpublished<br />
data), 99% of patients followed<br />
in both FFS and HMO systems<br />
had I or more comorbid c<strong>on</strong>diti<strong>on</strong>s; the<br />
most prevalent c<strong>on</strong>diti<strong>on</strong>s were back pain/<br />
sciatica (39% and 37% in FFS and HMO<br />
systems, respectively), musculoskeletal<br />
complaints (24% and 22%), dermatitis<br />
(17% in each), and varicosities (15%<br />
and 14%).<br />
L<strong>on</strong>gltudlnal Data Collecsi<strong>on</strong><br />
After screening in the physician's office<br />
and enrollment by teleph<strong>on</strong>e interview,<br />
each patient was sent a baseline<br />
health survey by mail.'° The baseline<br />
survey was completed, <strong>on</strong> average, 4<br />
m<strong>on</strong>ths afterthe patient's screening visit<br />
with an MOS clinician. Four-year followup<br />
data were obtained for 1574 of the<br />
2235 patients (70.4% of the l<strong>on</strong>gitudinal<br />
cohort). Patients were lost to follow-up<br />
for a variety of reas<strong>on</strong>s including refusals<br />
and failure to c<strong>on</strong>tact (n=661; 29.6%);<br />
137 (6.1%) who died during follow-up<br />
were included in the analysis. Analysis<br />
of initial health status for those lost to<br />
follow-up for reas<strong>on</strong>s other than death<br />
revealed no differences and loss to followup<br />
was equally likely in HMO and FFS<br />
systems. However, younger and poverty-stricken<br />
patients were more likely<br />
to be lost from both HMO and FFS<br />
systems. All analyses of outcomes adjusted<br />
for age, poverty status, and other<br />
variables to take into account this potential<br />
source of bias (see "Statistical<br />
Analysis").<br />
Health Status Measures<br />
Summary physical and mental health<br />
scales c<strong>on</strong>structed from the Medical<br />
Outcomes Study 36-Item Short-Form<br />
Health Survey (SF-6) were analyzed<br />
(Table 1). These summary measures<br />
capture 82% of the reliable variance in<br />
the 8 SF46 health scores estimated usiag<br />
the internal-c<strong>on</strong>sistency reliability<br />
method.>"" The c<strong>on</strong>structi<strong>on</strong> of summary<br />
measures, score reliability and validity,<br />
and normative and other interpretati<strong>on</strong><br />
guidelines are documented<br />
elsewhere."<br />
Changes in health were estimated in<br />
2 ways. First, baseline scores were subtracted<br />
from 4-year follow-updscores,<br />
with deaths assigned a follow-up physical<br />
health score of0 (Table 1). Although<br />
these average change scores have the<br />
advantage of reflecting the magnitude<br />
C1. 3r2ocalo y 1 eldery and P0M5 Paemts-Ware et a]